chr11-125957314-G-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001378964.1(CDON):​c.*3628C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00889 in 152,236 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0089 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CDON
NM_001378964.1 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.643

Publications

3 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
VSIG10L2 (HGNC:27879): (V-set and immunoglobulin domain containing 10 like 2) Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be active in cell-cell junction. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-125957314-G-C is Benign according to our data. Variant chr11-125957314-G-C is described in ClinVar as Benign. ClinVar VariationId is 303382.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 1353 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378964.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDON
NM_001378964.1
MANE Select
c.*3628C>G
3_prime_UTR
Exon 20 of 20NP_001365893.1Q4KMG0-2
CDON
NM_001243597.3
c.*3628C>G
3_prime_UTR
Exon 20 of 20NP_001230526.1
CDON
NM_001441161.1
c.*3628C>G
3_prime_UTR
Exon 20 of 20NP_001428090.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDON
ENST00000531738.6
TSL:1 MANE Select
c.*3628C>G
3_prime_UTR
Exon 20 of 20ENSP00000432901.2Q4KMG0-2
CDON
ENST00000392693.7
TSL:1
c.*3628C>G
3_prime_UTR
Exon 20 of 20ENSP00000376458.3Q4KMG0-1
CDON
ENST00000684078.1
c.*3628C>G
3_prime_UTR
Exon 20 of 20ENSP00000507318.1Q4KMG0-1

Frequencies

GnomAD3 genomes
AF:
0.00890
AC:
1354
AN:
152118
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.00536
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00679
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0145
Gnomad OTH
AF:
0.00671
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
64
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
42
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
54
Other (OTH)
AF:
0.00
AC:
0
AN:
4
GnomAD4 genome
AF:
0.00889
AC:
1353
AN:
152236
Hom.:
9
Cov.:
32
AF XY:
0.00821
AC XY:
611
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00287
AC:
119
AN:
41520
American (AMR)
AF:
0.00536
AC:
82
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4830
European-Finnish (FIN)
AF:
0.00679
AC:
72
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0145
AC:
987
AN:
68016
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
68
136
204
272
340
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
0
Bravo
AF:
0.00861
Asia WGS
AF:
0.000866
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Holoprosencephaly 11 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.30
DANN
Benign
0.61
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140783947; hg19: chr11-125827209; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.